BDBM186015 US9163010, Formula II

SMILES Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)N1CCOCCOCCOCC1

InChI Key InChIKey=AUNHGNQTPLHIRO-RGEXLXHISA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 186015   

TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Beta Pharma

US Patent
LigandPNGBDBM186015(US9163010, Formula II)
Affinity DataIC50:  2.5nMAssay Description:The effects of compound of formula II on inhibiting VEGFR were compared against that of sunitinib in vitro.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Beta Pharma

US Patent
LigandPNGBDBM186015(US9163010, Formula II)
Affinity DataIC50:  40nMAssay Description:The effects of compound of formula II on inhibiting VEGFR were compared against that of sunitinib in vitro.More data for this Ligand-Target Pair
In DepthDetails US Patent